Format
Sort by
Items per page

Send to

Choose Destination

Best matches for bipolar disorder AND bipolar i disorder AND lithium AND quality of care:

Comorbidity of bipolar disorder and eating disorders. Álvarez Ruiz EM et al. Rev Psiquiatr Salud Ment. (2015)

Effect of quetiapine XR on depressive symptoms and sleep quality compared with lithium in patients with bipolar depression. Kim SJ et al. J Affect Disord. (2014)

Neocortical levels of lithium are increased in bipolar disorder. Friedlich AL et al. Mol Psychiatry. (2012)

Search results

Items: 1 to 20 of 3088

1.

An overview of pharmacotherapy for bipolar I disorder.

Morsel AM, Morrens M, Sabbe B.

Expert Opin Pharmacother. 2018 Feb;19(3):203-222. doi: 10.1080/14656566.2018.1426746. Epub 2018 Jan 23. Review.

PMID:
29361880
2.

Lithium + Colchicine: A Potential Strategy to Reduce Pro-inflammatory Effects of Lithium Treatment.

Mooney JJ, Brady RO.

J Clin Psychopharmacol. 2018 Feb;38(1):80-85. doi: 10.1097/JCP.0000000000000830. Review.

PMID:
29232311
3.

Electroconvulsive therapy for manic state with mixed and psychotic features in a teenager with bipolar disorder and comorbid episodic obsessive-compulsive disorder: a case report.

Rask O, Suneson K, Holmström E, Bäckström B, Johansson BA.

J Med Case Rep. 2017 Dec 12;11(1):345. doi: 10.1186/s13256-017-1508-8.

4.

GERI-BD: A Randomized Double-Blind Controlled Trial of Lithium and Divalproex in the Treatment of Mania in Older Patients With Bipolar Disorder.

Young RC, Mulsant BH, Sajatovic M, Gildengers AG, Gyulai L, Al Jurdi RK, Beyer J, Evans J, Banerjee S, Greenberg R, Marino P, Kunik ME, Chen P, Barrett M, Schulberg HC, Bruce ML, Reynolds CF 3rd, Alexopoulos GS; GERI-BD Study Group.

Am J Psychiatry. 2017 Nov 1;174(11):1086-1093. doi: 10.1176/appi.ajp.2017.15050657. Epub 2017 Aug 4.

PMID:
29088928
5.

Continuation of lithium after a diagnosis of chronic kidney disease.

Kessing LV, Feldt-Rasmussen B, Andersen PK, Gerds TA, Licht RW.

Acta Psychiatr Scand. 2017 Dec;136(6):615-622. doi: 10.1111/acps.12820. Epub 2017 Oct 19.

PMID:
29049864
6.

Risks of road injuries in patients with bipolar disorder and associations with drug treatments: A population-based matched cohort study.

Chen VC, Yang YH, Lee CP, Wong J, Ponton L, Lee Y, McIntyre RS, Huang KY, Wu SI.

J Affect Disord. 2018 Jan 15;226:124-131. doi: 10.1016/j.jad.2017.09.029. Epub 2017 Sep 23.

PMID:
28972929
7.

Clinically relevant treatment considerations regarding lithium use in bipolar disorder.

Richardson T, Macaluso M.

Expert Opin Drug Metab Toxicol. 2017 Nov;13(11):1105-1113. doi: 10.1080/17425255.2017.1386653. Epub 2017 Oct 9. Review.

PMID:
28965429
8.

Lurasidone: efficacy and safety in the treatment of psychotic and mood disorders.

Pompili M, Verzura C, Trovini G, Buscajoni A, Falcone G, Naim S, Nardella A, Sorice S, Baldessarini RJ, Girardi P.

Expert Opin Drug Saf. 2018 Feb;17(2):197-205. doi: 10.1080/14740338.2017.1379989. Epub 2017 Sep 26. Review.

PMID:
28902525
9.

Sleep disturbance may impact treatment outcome in bipolar disorder: A preliminary investigation in the context of a large comparative effectiveness trial.

Sylvia LG, Chang WC, Kamali M, Tohen M, Kinrys G, Deckersbach T, Calabrese JR, Thase ME, Reilly-Harrington N, Bobo WV, Kocsis JH, McInnis MG, Bowden CL, Ketter TA, Friedman ES, Shelton RC, McElroy SL, Gao K, Rabideau DJ, Nierenberg AA.

J Affect Disord. 2018 Jan 1;225:563-568. doi: 10.1016/j.jad.2017.08.056. Epub 2017 Aug 19.

PMID:
28881294
10.

Precision medicine for suicidality: from universality to subtypes and personalization.

Niculescu AB, Le-Niculescu H, Levey DF, Phalen PL, Dainton HL, Roseberry K, Niculescu EM, Niezer JO, Williams A, Graham DL, Jones TJ, Venugopal V, Ballew A, Yard M, Gelbart T, Kurian SM, Shekhar A, Schork NJ, Sandusky GE, Salomon DR.

Mol Psychiatry. 2017 Sep;22(9):1250-1273. doi: 10.1038/mp.2017.128. Epub 2017 Aug 15.

11.

Lithium monotherapy associated clinical improvement effects on amygdala-ventromedial prefrontal cortex resting state connectivity in bipolar disorder.

Altinay M, Karne H, Anand A.

J Affect Disord. 2018 Jan 1;225:4-12. doi: 10.1016/j.jad.2017.06.047. Epub 2017 Jun 27.

PMID:
28772145
12.

Trajectories of suicidal ideation over 6 months among 482 outpatients with bipolar disorder.

Köhler-Forsberg O, Madsen T, Behrendt-Møller I, Sylvia L, Bowden CL, Gao K, Bobo WV, Trivedi MH, Calabrese JR, Thase M, Shelton RC, McInnis M, Tohen M, Ketter TA, Friedman ES, Deckersbach T, McElroy SL, Reilly-Harrington NA, Nierenberg AA.

J Affect Disord. 2017 Dec 1;223:146-152. doi: 10.1016/j.jad.2017.07.038. Epub 2017 Jul 20.

PMID:
28755622
13.

The relationship between brain volumes and intelligence in bipolar disorder.

Vreeker A, Abramovic L, Boks MPM, Verkooijen S, van Bergen AH, Ophoff RA, Kahn RS, van Haren NEM.

J Affect Disord. 2017 Dec 1;223:59-64. doi: 10.1016/j.jad.2017.07.009. Epub 2017 Jul 6.

PMID:
28728036
14.

Pharmacological Treatment of Bipolar Disorder with Comorbid Alcohol Use Disorder.

Naglich A, Adinoff B, Brown ES.

CNS Drugs. 2017 Aug;31(8):665-674. doi: 10.1007/s40263-017-0449-5.

PMID:
28669022
15.

A Prospective Study of Adverse Drug Reactions in Patients with Bipolar Disorder in Psychiatry Outpatient Department of a Tertiary Care Hospital.

Shah A, Yadav PP, Chaudhari M, Vataliya A, Kantharia ND, Mehta R.

J Clin Diagn Res. 2017 May;11(5):FC24-FC28. doi: 10.7860/JCDR/2017/24009.9873. Epub 2017 May 1.

16.

Thyroid autoimmunity in bipolar disorder: A systematic review.

Barbuti M, Carvalho AF, Köhler CA, Murru A, Verdolini N, Guiso G, Samalin L, Maes M, Stubbs B, Perugi G, Vieta E, Pacchiarotti I.

J Affect Disord. 2017 Oct 15;221:97-106. doi: 10.1016/j.jad.2017.06.019. Epub 2017 Jun 13. Review.

PMID:
28641149
17.

Atypical antipsychotic use and outcomes in an urban maternal mental health service.

Hatters Friedman S, Moller-Olsen C, Prakash C, North A.

Int J Psychiatry Med. 2016 Aug;51(6):521-533. doi: 10.1177/0091217417696739. Epub 2017 Mar 6.

PMID:
28629296
18.

Complex psychotropic polypharmacy in bipolar disorder across varying mood polarities: A prospective cohort study of 2712 inpatients.

Golden JC, Goethe JW, Woolley SB.

J Affect Disord. 2017 Oct 15;221:6-10. doi: 10.1016/j.jad.2017.06.005. Epub 2017 Jun 13.

PMID:
28628769
19.

Lithium-induced NDI: acetazolamide reduces polyuria but does not improve urine concentrating ability.

de Groot T, Doornebal J, Christensen BM, Cockx S, Sinke AP, Baumgarten R, Bedford JJ, Walker RJ, Wetzels JFM, Deen PMT.

Am J Physiol Renal Physiol. 2017 Sep 1;313(3):F669-F676. doi: 10.1152/ajprenal.00147.2017. Epub 2017 Jun 14.

PMID:
28615247
20.

Lithium ameliorates sleep deprivation-induced mania-like behavior, hypothalamic-pituitary-adrenal (HPA) axis alterations, oxidative stress and elevations of cytokine concentrations in the brain and serum of mice.

Valvassori SS, Resende WR, Dal-Pont G, Sangaletti-Pereira H, Gava FF, Peterle BR, Carvalho AF, Varela RB, Dal-Pizzol F, Quevedo J.

Bipolar Disord. 2017 Jun;19(4):246-258. doi: 10.1111/bdi.12503. Epub 2017 Jun 14.

PMID:
28612976

Supplemental Content

Loading ...
Support Center